Skip to main content

Houlihan Capital

Houlihan Capital Advised on the Recapitalization of DocMJ by Chatham Capital

Houlihan Capital’s Investment Banking Group is pleased to announce the following transaction: October 2021 Recapitalization of DocMJ Debt & Equity Provided by Chatham Capital Sector: Ancillary Services – Cannabis Houlihan Capital acted as the exclusive financial advisor to DocMJ, the leading group of medical marijuana doctors in the state of Florida, on its recapitalization through […]

Quarterly Industry Report Updates are Available for Q1 2022

Houlihan Capital provides Quarterly Updates on the following industries as of March 31, 2022. Information includes valuation metrics, performance data and M&A activity. Click on the following links below to access reports for the following industries: Aerospace, Defense & Government Asset Management Banking Building Products Business Services Cannabis Chemicals Consumer Products Internet Retail Media and […]

Michael Norton, Director, Named as “M&A Business Development Professionals to Watch”

Houlihan Capital is excited to share that Michael Norton, Director – Business Development, was featured on Middle Market Growth’s 2022 – Business Development Report and listed as M&A Business Development Professionals to Watch. In an article on page 68 titled, “In-Person Networking is Back: Now What?”, Mr. Norton provides networking advice and pro tips for […]

Our New Branch Office in Cleveland, OH!

Houlihan Capital is excited to announce we have expanded with a new branch office in Cleveland, OH. Our new address is: 2400 Superior Ave East, 1st Floor Cleveland, OH 44114 (312) 450-8600 Houlihan Capital is committed to delivering superior client value. We look forward to continuing to serve our clients and relationships from our new […]